[dt_vc_list style=”2″ bullet_position=”middle”]

• Health Technolohy Assessment Practices in Turkey

[/dt_vc_list]

[dt_vc_list style=”2″ bullet_position=”middle”]

• Cost-Effectiveness of Certolizumab Pegol for the Treatment of Axial Spondyloarthritis in Turkey
• Cost Effectiveness of Sodium Oxybate in Treatment of Cataplexy in Patients With Narcolepy in Turkey

[/dt_vc_list]

[dt_vc_list style=”2″ bullet_position=”middle”]

• Cost Effectiveness of Sodıum Oxybate in Treatment Of Cataplexy in Patients With Narcolepsy in Turkey
• Cost of Familial Mediterranean Fever (Fmf) Disease in Turkey
• Cost Saving Study of Five Grass Pollen Slit Tablet Versus Scit’s & Symptomatic Treatment
• Cost-Effectiveness of Certolizumab Pegol for the Treatment of Axial Spondyloarthritis in Turkey
• Direct Treatment Costs of Stroke in Turkey
• How Pricing and Reimbursement Policies Affect The Budget Impact Of The Treatment Of Systemic Juvenile Idiopathic Arthritis In Turkey
• Local Cost Study of Treatment of Venous Thromboembolism in Turkey

[/dt_vc_list]

[dt_vc_list style=”2″ bullet_position=”middle”]

•  Impact of Healthcare Reforms on Prıcıng and Reımbursement in Turkey 
• The Most Profitable Health Insurance “Company” in Turkey 
• Atc1 Group Discount Distribution Analysıs of Original Medicines Which Has No Generics in Turkey 
• Impact of Healthcare Reforms on Pricing and Reimbursement in Turkey 
• Comparison of Pharmaceutical Pricing and Reimbursement Systems in Turkey and Certain EU Countries 
• Pricing and Reimbursement Policies of Turkey and Ukraine

[/dt_vc_list]

[dt_vc_list style=”2″ bullet_position=”middle”]

• General Assessment of Unlicensed Medicine Usage in Turkey
• General Assessment of Unlicensed Antineoplastic and Immunomodulating Medicine Usage Subgroups in Turkey
• The Most Profitable Health Insurance “Company” in Turkey
• Discount Distribution Analysıs Of Original Medicines Which Has No Generics in Turkey
• An Analysis of Diabetic Medicine Utilization in TURKEY
• Atc1 Group Discount Distribution Analysis Of Original Medicines Which Has No Generics in Turkey
• General Assessment of Unlicensed Antineoplastic and Immunomodulating Medicine Usage in Turkey

[/dt_vc_list]

[dt_vc_list style=”2″ bullet_position=”middle”]

• Value of Life and Cost of Pre-mature Deaths with the Perspective of Productivity as Net Tax Revenue: A Comparison in France, Germany, Italy, Spain, United Kingdom

[/dt_vc_list]

[dt_vc_list style=”2″ bullet_position=”middle”]

• Impact of Health Policy Changes on Unit Sales Of 5 Top Sellıng Atc1 Pharmaceutical Groups in Turkey

[/dt_vc_list]

[dt_vc_list style=”2″ bullet_position=”middle”]

• Impact of Health Policy Changes on Trends of Pharmaceutıcal Market in Turkey

[/dt_vc_list]

[dt_vc_list style=”2″ bullet_position=”middle”]

• Value of Life and Cost of Pre-mature Deaths with the Perspective of Productivity as Net Tax Revenue: A Comparison in USA, Canada,Japan and Australia
• The Trend oft he Pricesofnew Marketed Drugs Inturkey 
• Impact of Health Policy Changes on Trends of Pharmaceutical Market in Turkey 

[/dt_vc_list]

[dt_vc_list style=”2″ bullet_position=”middle”]

• Value of Life and Cost of Pre-mature Deaths with the Perspective of Productivity as Net Tax Revenue: A Comparison in Argentina,Brazil and Mexico

[/dt_vc_list]

[dt_vc_list style=”2″ bullet_position=”middle”]

• Impact of Health Policy Changes on the Growth Locally Manufactured and Imported Pharmaceutical Markets in Turkey
• Unutulmaz bir gece yaşamak istiyorsanız mersin escort kızların sayfasını papim.net sitesine girerek ziyaret edebilirsiniz.

[/dt_vc_list]

[dt_vc_list style=”2″ bullet_position=”middle”]

• Value of Life and Cost of Pre-mature Deaths with the Perspective of Productivity as Net Tax Revenuefor Turkey
• Impact of Health Policy Changes on the Growth Locally Manufactured and Imported Pharmaceutical Markets of Top Selling ATC1 Pharmaceutical Group (Alimentary and Metabolism (A0) in Turkey

[/dt_vc_list]